JusticeNotableSingle-sourceDeveloping
5.0
BRB claims victim of criminal acts amid Master portfolio fraud probe
Valor Econômico·BR·3 days ago
Oncoclínicas appointed Maurício Hasson as CFO and IR director, replacing interim Isaac Quintino, who will stay for transition. Hasson returns after a decade, having previously served at the company and at Pernambucanas. This is a routine executive change with no immediate market impact.